中华儿科杂志
中華兒科雜誌
중화인과잡지
Chinese Journal of Pediatrics
2012年
10期
777-781
,共5页
张传领%沈利蒙%楚旭%毛剑锋%董华丽
張傳領%瀋利矇%楚旭%毛劍鋒%董華麗
장전령%침리몽%초욱%모검봉%동화려
儿童%志贺菌属%β内酰胺酶类%抗药性
兒童%誌賀菌屬%β內酰胺酶類%抗藥性
인동%지하균속%β내선알매류%항약성
Child%Shigella%beta-Lactamases%Drug resistance
目的 调查腹泻儿童临床分离志贺菌的流行及其耐药性,为细菌性痢疾临床治疗和感染控制提供理论依据.方法 收集2008年1月至2010年12月浙江萧山医院就诊的≤14岁腹泻患儿粪便分离的志贺菌156株,纸片扩散检测其抗菌药物的耐药性,纸片确认试验检测产超广谱β内酰胺酶(ESBLs);采用细菌基因组重复序列聚合酶链反应(REP-PCR)检测产ESBLs宋内志贺菌的分子流行病学特征.结果 156株志贺菌中主要为宋内志贺菌(130株,占83.3%)和福氏志贺菌(26株,占16.7%),81株志贺菌产ESBLs,阳性率为51.9%,各年的阳性率分别为2008年32.0%、2009年41.4%、2010年59.8%.药敏结果显示,产ESBLs志贺菌对氨苄西林、复方新诺明、头孢噻肟、哌拉西林耐药率均>90%,而对头孢吡肟、头孢他啶、左氧氟沙星、环丙沙星耐药率较低;产ESBLs志贺菌与非产ESBLs志贺菌相比,对哌拉西林(100% vs.77.3%)、头孢噻肟(100% vs.0)、头孢他啶(14.8% vs.0)、头孢吡肟(28.4% vs.0)、复方新诺明(95.1% vs.86.7%)的耐药率均较高(x2值分别为20.605,156.000,12.037,24.979,45.040;P均<0.05),未发现亚胺培南、哌拉西林-他唑巴坦耐药菌株.74株产ESBLs宋内志贺菌共分为7个基因型:A型50株,B型12株,C型8株,D、E、F、G型各1株.结论 分离自腹泻患儿的志贺菌产ESBLs阳性率较高,且有逐年增加的趋势;近年来宋内志贺菌存在同一克隆株A型的流行;哌拉西林-他唑巴坦可作为临床治疗儿童感染产ESBLs志贺菌的首选药物.
目的 調查腹瀉兒童臨床分離誌賀菌的流行及其耐藥性,為細菌性痢疾臨床治療和感染控製提供理論依據.方法 收集2008年1月至2010年12月浙江蕭山醫院就診的≤14歲腹瀉患兒糞便分離的誌賀菌156株,紙片擴散檢測其抗菌藥物的耐藥性,紙片確認試驗檢測產超廣譜β內酰胺酶(ESBLs);採用細菌基因組重複序列聚閤酶鏈反應(REP-PCR)檢測產ESBLs宋內誌賀菌的分子流行病學特徵.結果 156株誌賀菌中主要為宋內誌賀菌(130株,佔83.3%)和福氏誌賀菌(26株,佔16.7%),81株誌賀菌產ESBLs,暘性率為51.9%,各年的暘性率分彆為2008年32.0%、2009年41.4%、2010年59.8%.藥敏結果顯示,產ESBLs誌賀菌對氨芐西林、複方新諾明、頭孢噻肟、哌拉西林耐藥率均>90%,而對頭孢吡肟、頭孢他啶、左氧氟沙星、環丙沙星耐藥率較低;產ESBLs誌賀菌與非產ESBLs誌賀菌相比,對哌拉西林(100% vs.77.3%)、頭孢噻肟(100% vs.0)、頭孢他啶(14.8% vs.0)、頭孢吡肟(28.4% vs.0)、複方新諾明(95.1% vs.86.7%)的耐藥率均較高(x2值分彆為20.605,156.000,12.037,24.979,45.040;P均<0.05),未髮現亞胺培南、哌拉西林-他唑巴坦耐藥菌株.74株產ESBLs宋內誌賀菌共分為7箇基因型:A型50株,B型12株,C型8株,D、E、F、G型各1株.結論 分離自腹瀉患兒的誌賀菌產ESBLs暘性率較高,且有逐年增加的趨勢;近年來宋內誌賀菌存在同一剋隆株A型的流行;哌拉西林-他唑巴坦可作為臨床治療兒童感染產ESBLs誌賀菌的首選藥物.
목적 조사복사인동림상분리지하균적류행급기내약성,위세균성이질림상치료화감염공제제공이론의거.방법 수집2008년1월지2010년12월절강소산의원취진적≤14세복사환인분편분리적지하균156주,지편확산검측기항균약물적내약성,지편학인시험검측산초엄보β내선알매(ESBLs);채용세균기인조중복서렬취합매련반응(REP-PCR)검측산ESBLs송내지하균적분자류행병학특정.결과 156주지하균중주요위송내지하균(130주,점83.3%)화복씨지하균(26주,점16.7%),81주지하균산ESBLs,양성솔위51.9%,각년적양성솔분별위2008년32.0%、2009년41.4%、2010년59.8%.약민결과현시,산ESBLs지하균대안변서림、복방신낙명、두포새우、고랍서림내약솔균>90%,이대두포필우、두포타정、좌양불사성、배병사성내약솔교저;산ESBLs지하균여비산ESBLs지하균상비,대고랍서림(100% vs.77.3%)、두포새우(100% vs.0)、두포타정(14.8% vs.0)、두포필우(28.4% vs.0)、복방신낙명(95.1% vs.86.7%)적내약솔균교고(x2치분별위20.605,156.000,12.037,24.979,45.040;P균<0.05),미발현아알배남、고랍서림-타서파탄내약균주.74주산ESBLs송내지하균공분위7개기인형:A형50주,B형12주,C형8주,D、E、F、G형각1주.결론 분리자복사환인적지하균산ESBLs양성솔교고,차유축년증가적추세;근년래송내지하균존재동일극륭주A형적류행;고랍서림-타서파탄가작위림상치료인동감염산ESBLs지하균적수선약물.
Objective To investigate the prevalence and antibiotic resistance of Shigella isolated from children with diarrhea for the guidance of clinical treatment and prevention and control of bacillary dysentery.Method A total of 156 strains of Shigella were isolated from feces of children with diarrhea in Zhejiang Xiaoshan Hospital from January 2008 to December 2010.The antimicrobial resistance of the strains was detected by disk diffusion method and the extended-spectrum beta-lactamases (ESBLs) in these isolates were determined using phenotypic confirmatory test; the isolates of ESBLs producing Shigella sonnei were analyzed by REP-PCR.Result Among 156 strains of Shigella isolated,the most common groups were Shigella sonnei (130 strains,accounting for 83.3%) and Shigella fleaneri (26 strains,accounting for 16.7%),and 81 (51.9%) strains were identified as ESBLs producers,and the positive rates in 2008,2009 and 2010 were 32.0%,41.4% and 59.8%,respectively.The results of antibiotic susceptibility test displayed that the resistance rates of ESBLs producing Shigella to ampicillin,cotrimoxazole,cefotaxime,piperacillin were higher than 90%.However,the resistance rates to cefepime,ceftazidime,levofloxacin and ciprofloxacin were low; The resistance of ESBLs producing strains to piperacillin (100% vs.77.3%),cefotaxime(100% vs.0),ceftazidime(14.8% vs.0),cefepime(28.4% vs.0),cotrimoxazole(95.1%vs.86.7%) was significantly higher than that of non-ESBLs producing strains (x2 =20.605,156.000,12.037,24.979,45.040,respectively ;P < 0.05).No isolate was resistant to piperacillin/tazobactam and imipenem.There were 7 genotypes among 74 ESBLs producing Shigella sonnei,respectively type A (50),type B (12),type C (8),type D (1),type E (1),type F (1),and type G (1).Conclusion The isolation rate of ESBLs-producing isolate was high in Shigella from pediatric patients with diarrhea,and the number is going up year by year,and these ESBLs producing Shigella sonnei strains in genotype A are dominant in recent years,Piperacillin/tazobactam is the drug of choice for children with ESBLs producing Shigella infection.